Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients.
Loading...
Embargo End Date
ICR Authors
Authors
Shah, V
Sherborne, AL
Johnson, DC
Ellis, S
Price, A
Chowdhury, F
Kendall, J
Jenner, MW
Drayson, MT
Owen, RG
Gregory, WM
Morgan, GJ
Davies, FE
Cook, G
Cairns, DA
Houlston, RS
Jackson, G
Kaiser, MF
on behalf of NCRI Haematology Clinical Studies Group,
Sherborne, AL
Johnson, DC
Ellis, S
Price, A
Chowdhury, F
Kendall, J
Jenner, MW
Drayson, MT
Owen, RG
Gregory, WM
Morgan, GJ
Davies, FE
Cook, G
Cairns, DA
Houlston, RS
Jackson, G
Kaiser, MF
on behalf of NCRI Haematology Clinical Studies Group,
Document Type
Journal Article
Date
2020-03-11
Date Accepted
2020-02-06
Abstract
Citation
Leukemia, 2020, 34 (11), pp. 3091 - 3096
Source Title
Publisher
SPRINGERNATURE
ISSN
0887-6924
eISSN
1476-5551
Collections
Research Team
Cancer Genomics
Myeloma Group
Myeloma Group